Breathe Well Live Well
|
Building Industry Organization Urges American Consumers, Businesses and Builders to Assist in the Prevention of …
GlobeNewswire (press release) “Asthma can be a life threatening condition for many Americans and finding and implementing solutions for reducing asthma triggers should be a top priority for all,” said Kurt Riesenberg, Executive Director of the Spray Polyurethane Foam Alliance … |
View full post on asthma – Google News
|
ALK announces top-line results from the five-year landmark GRAZAX® Asthma …
GlobeNewswire (press release) The trial did not show an effect in terms of time to first diagnosis of reversible impairment of lung function. The trial demonstrated that GRAZAX® treatment significantly reduced the proportion of children experiencing asthma symptoms or using asthma … BRIEF-Alk Abello announces results from GRAZAX Asthma Prevention trial in children ALK announces top-line results from the five-year landmark GRAZAX(r) Asthma … |
View full post on asthma – Google News
Patriarc |
Asthma Therapeutics in Major Developed Market 2015 – Global Market Size, Share …
GlobeNewswire (press release) ResearchMoz added a new report titled "Asthma Therapeutics in Major Developed Markets to 2020 – Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations" to its Research Report collection. Global Asthma Therapeutics Industry 2015 Market Research Report |
View full post on asthma – Google News
|
U.S. Asthma Costs Reach $18 Billion
GlobeNewswire (press release) FRISCO, Texas, April 1, 2015 (GLOBE NEWSWIRE) — According to the Asthma and Allergy Foundation of America, 25 million Americans suffer from asthma (8% of adults, 9% of children). The disease accounts for one-quarter of all U.S. emergency room visits. |
View full post on asthma – Google News
|
AB Science: Web conference on masitinib in asthma – Safety and Efficacy Update
GlobeNewswire (press release) Paris, France, Nov. 25, 2014 (GLOBE NEWSWIRE) — AB Science SA (NYSE Euronext – FR0010557264 – AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), is hosting a web … |
View full post on asthma – Google News
|
NeoStem Forms Advisory Group of Experts for Steroid Resistant Asthma
GlobeNewswire (press release) NEW YORK, Sept. 9, 2013 (GLOBE NEWSWIRE) — NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, is pleased to announce that three experts at the forefront of asthma research have agreed to … NeoStem (NASDAQ: NBS) Forms Advisory Group for Steroid Resistant Asthma |
View full post on asthma – Google News
|
Joint Venture Announced
GlobeNewsWire (press release) We are very pleased to be joining with MediciNova in providing better solutions for asthma patients" MN-221 is a novel, highly selective, beta2-adrenergic receptor agonist in development as an intravenous treatment for acute exacerbations of asthma and … |
View full post on asthma – Google News